• Return to Headlines

Uptrend Call Working As Questcor Pharmaceuticals Stock Rises 32.2% (QCOR)

By David Diaz

SmarTrend identified an Uptrend for Questcor Pharmaceuticals (NASDAQ:QCOR) on October 16th, 2012 at $24.71. In approximately 5 months, Questcor Pharmaceuticals has returned 32.21% as of today's recent price of $32.67.

In the past 52 weeks, shares of Questcor Pharmaceuticals have traded between a low of $14.52 and a high of $58.91 and are now at $32.67, which is 125% above that low price. The 200-day and 50-day moving averages have moved 0.51% lower and 1.38% higher over the past week, respectively.

Questcor Pharmaceuticals, Inc. develops and commercializes novel central nervous system-focused therapeutics that address significant unmet medical needs. The Company's primary product is a natural source adrenocorticotropic hormone indicated for the treatment of acute exacerbations of multiple sclerosis, as well as a number of other conditions.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Questcor Pharmaceuticals shares.

Log in and add Questcor Pharmaceuticals (QCOR) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights questcor pharmaceuticals

Ticker(s): QCOR